Segall Bryant & Hamill’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
Segall Bryant & Hamill's ACLS Position: Q2 2026 in Review
Segall Bryant & Hamill sold out of Axcelis (ACLS) in Q2 2026, closing a stake of 200,371 shares — an estimated $18.7M sold.
Segall Bryant & Hamill first reported a position in ACLS in Q4 2013 and held it in 16 quarters. The position peaked at $18.7M in Q1 2026. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- Segall Bryant & Hamill reported no remaining Axcelis position as of Q2 2026 after selling out during the quarter.
- Segall Bryant & Hamill sold 200,371 Axcelis shares in Q2 2026, an estimated $18.7M.
- Segall Bryant & Hamill first reported a position in Axcelis in Q4 2013 and held it in 16 quarters.
- Segall Bryant & Hamill's Axcelis position peaked at $18.7M in Q1 2026.
- 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.